Fulgent Genetics Share Holder Equity 2015-2025 | FLGT
Fulgent Genetics share holder equity from 2015 to 2025. Share holder equity can be defined as the sum of preferred and common equity items
| Fulgent Genetics Annual Share Holder Equity (Millions of US $) |
|
|---|---|
| 2024 | $1,129 |
| 2023 | $1,133 |
| 2022 | $1,270 |
| 2021 | $1,166 |
| 2020 | $569 |
| 2019 | $83 |
| 2018 | $51 |
| 2017 | $54 |
| 2016 | $54 |
| 2015 | $5 |
| 2014 | $2 |
| Fulgent Genetics Quarterly Share Holder Equity (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,123 |
| 2024-12-31 | $1,129 |
| 2024-09-30 | $1,135 |
| 2024-06-30 | $1,129 |
| 2024-03-31 | $1,127 |
| 2023-12-31 | $1,133 |
| 2023-09-30 | $1,262 |
| 2023-06-30 | $1,263 |
| 2023-03-31 | $1,269 |
| 2022-12-31 | $1,270 |
| 2022-09-30 | $1,281 |
| 2022-06-30 | $1,311 |
| 2022-03-31 | $1,313 |
| 2021-12-31 | $1,166 |
| 2021-09-30 | $1,044 |
| 2021-06-30 | $921 |
| 2021-03-31 | $802 |
| 2020-12-31 | $569 |
| 2020-09-30 | $187 |
| 2020-06-30 | $87 |
| 2020-03-31 | $81 |
| 2019-12-31 | $83 |
| 2019-09-30 | $55 |
| 2019-06-30 | $51 |
| 2019-03-31 | $50 |
| 2018-12-31 | $51 |
| 2018-09-30 | $53 |
| 2018-06-30 | $53 |
| 2018-03-31 | $53 |
| 2017-12-31 | $54 |
| 2017-09-30 | $55 |
| 2017-06-30 | $56 |
| 2017-03-31 | $55 |
| 2016-12-31 | $54 |
| 2016-09-30 | $17 |
| 2016-06-30 | $22 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2014-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.618B | $0.283B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.908B | 52.36 |
| Hims & Hers Health (HIMS) | United States | $12.273B | 127.51 |
| Tempus AI (TEM) | United States | $10.774B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.555B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.224B | 66.00 |
| Privia Health (PRVA) | United States | $2.787B | 190.50 |
| Enovis (ENOV) | United States | $1.803B | 10.05 |
| Clover Health Investments (CLOV) | United States | $1.623B | 0.00 |
| Schrodinger (SDGR) | United States | $1.563B | 0.00 |
| Phreesia (PHR) | United States | $1.431B | 0.00 |
| Omnicell (OMCL) | United States | $1.322B | 23.33 |
| Azenta (AZTA) | United States | $1.236B | 57.45 |
| 10x Genomics (TXG) | United States | $1.006B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.537B | 0.00 |
| Veradigm (MDRX) | United States | $0.476B | 0.00 |
| Talkspace (TALK) | United States | $0.472B | 141.00 |
| Claritev (CTEV) | United States | $0.437B | 0.00 |
| TruBridge (TBRG) | United States | $0.357B | 791.00 |
| Standard BioTools (LAB) | United States | $0.350B | 0.00 |
| Outset Medical (OM) | United States | $0.318B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.264B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.190B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.140B | 0.00 |
| Pulmonx (LUNG) | United States | $0.125B | 0.00 |
| American Well (AMWL) | United States | $0.116B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.096B | 0.00 |
| CareCloud (CCLD) | United States | $0.084B | 3.21 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.056B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.052B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.026B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.017B | 0.00 |
| Precipio (PRPO) | United States | $0.015B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |